Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice

Author: Irwin N.   McClean P.   O’Harte F.   Gault V.   Harriott P.   Flatt P.  

Publisher: Springer Publishing Company

ISSN: 0012-186X

Source: Diabetologia, Vol.50, Iss.7, 2007-07, pp. : 1532-1540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content